KAYKHOSROW HOOSHMAND-PARSI: Open Payments
NPI 1447291851 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 31 payments from 12 companies in 2025. Trend: 2023 $407 · 2024 $393 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $145 |
| Indivior Inc. | 6 | $102 |
| Astellas Pharma US Inc | 3 | $76 |
| Lilly USA, LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| ABBVIE INC. | 2 | $43 |
| Hologic Sales and Service, LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Amgen Inc. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: SUBLOCADE, Veozah, Wegovy, MOUNJARO, REXULTI, Ozempic, Rybelsus, MAVYRET.
Industry payments across CO — which companies pay providers there.
